Skip to content

Pioneering a new approach to biological discovery

IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.

Our proteins power discovery

IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.

About IPI

Woman in glasses and lab coat holding pipette.

Academic expertise

Our Harvard-based scientists collaboratively take on complex projects in the areas most in need of transformative antibodies and other proteins.

Learn about our research

Man working in cell biology lab.

Industrial platform

We achieve unprecedented scale with a platform and technologies based on high-quality protein and antibody design, expression and production.

Learn about our Platform

IPI in brief

Drawing Of Microscope.

Meeting research needs

IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Basic Drawing Of Antibody.

Best of both worlds

IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Figure Representing Business Model.

Unique business model

IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Drawing Of Lightbulb.

Cross-disciplinary connections

IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.

Building collaborations

IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.

News from the lab

“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

“A wise man always keeps learning”: Biotech entrepreneur Rusty Williams joins IPI Board

In 1984, Lewis “Rusty” Williams boarded a flight from Boston to San Francisco and took the last open seat near the back of the plane. Williams,...

Read more

Engineering for efficiency: André Teixeira takes charge of antibody discovery and library design at IPI

It’s a few minutes after noon, and scientists at the Institute for Protein Innovation (IPI) are eating in the conference room. The conversation turns to IPI’s...

Read more

Entry points into neuroscience: A Q&A with Thomas Biederer

At the heart of all nervous system functions are the synapses, where signals fly between neurons in swarms of molecular activity. Thomas Biederer is intent on...

Read more
At Cell Bio 2023, a multidisciplinary panel suggests solutions for antibody validation

At Cell Bio 2023, a multidisciplinary panel suggests solutions for antibody validation

Speakers and panelists gather after the "Antibody Validation: A Call to Action" session hosted by YCharOS at Cell Bio 2023. Antibodies are among biologists’ most essential...

Read more

Get in touch today

Back To Top